GlassScriptPhysician profile
George Turini
NPI 1508095936
$1,427.15
in general payments reported to CMS, 2019-2025
15 companies · $654 in 2025
The $654 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $88.99 · 2021: $55.00 · 2022: $91.59 · 2023: $103 · 2024: $110 · 2025: $654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $867.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $279.20 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $174.32 | 2025 | Gemtesa |
| Immunitybio, INC. | $173.67 | 2025 | |
| Teleflex LLC | $149.11 | 2025 | Barrigel |
| Urogen Pharma, INC. | $112.62 | 2025 | |
| Progenics Pharmaceuticals, INC. | $109.92 | 2024 | |
| Boston Scientific Corporation | $103.00 | 2023 | Moses 550 D\F\L |
| Myovant Sciences INC. | $91.59 | 2022 | |
| Janssen Biotech, INC. | $74.79 | 2019 | |
| Coloplast Corp | $48.19 | 2019-2020 | |
| Pfizer INC. | $29.03 | 2020 | |
| Procept Biorobotics Corporation | $27.03 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $24.62 | 2019 | |
| Blue Earth Diagnostics | $16.23 | 2019 | |
| Becton, Dickinson and Company | $13.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Turini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.